Bombay HC Grants Ex Parte Ad Interim Relief To Sun Pharma In Trademark Infringement Case

ANM Global represented Sun Pharma Laboratories Limited who filed a suit before Bombay High Court against Arbour Biotec Private Limited and Anr. for infringement of trademark combined with a cause of action for passing off pertaining to its ‘QUTIPIN’ mark. The Defendants were found to be selling the impugned goods under an almost identical and deceptively similar mark, ‘QTAPIN’.

The Bombay High Court, upon hearing the Plaintiff, issued an ex-parte ad-interim injunction restraining the Defendants from selling infringing goods bearing the impugned mark and appointed Court Receivers to conduct raid.

Sun Pharma, a pharmaceutical company, highlighted the extensive use and registration of 'QUTIPIN' since 2002, reinforcing its claim to exclusive rights under Indian trademark law.

Intellectual property violations are treated with utmost seriousness by Courts, which have consistently led the charge in swiftly granting relief to halt such unlawful practices. These interventions not only safeguard companies from the proliferation of counterfeit/infringing goods but also broadcast a resolute message to other infringers which is  ‘unauthorised use will be met with robust and decisive measures’.

Sun Pharma Laboratories Limited was represented by Mr. Hiren Kamod, Advocate a/w Mr. Rahul Dhote, Mr. Shwetank Tripathi, Mr. Vidit Desai and Ms. Radhika Mehta & Pallavi Thakur Advocates i/b ANM Global for the Plaintiff.